HP Names Emma Walmsley CEO in Bet on Outside Leadership
HP taps former GlaxoSmithKline chief Emma Walmsley as CEO, testing whether an outsider from pharma and cosmetics can revive the PC and printer giant.
HP Inc. has selected Emma Walmsley, the former chief executive of GlaxoSmithKline, as its next chief executive officer, according to reports, placing a veteran of the pharmaceutical and consumer cosmetics industries at the helm of one of the world's most recognized personal computing brands.
Walmsley's appointment marks a striking departure from conventional succession logic at a hardware-focused company. Her career trajectory — running consumer healthcare and beauty divisions before leading a major global drugmaker — gives her little direct background in semiconductors, PC supply chains, or printer consumables, the core revenue drivers at HP.
Read more Labubu Collectible Craze Fades as Pop Mart Revenue Drops →
The selection echoes a broader corporate trend of importing transformational leaders from unrelated sectors when boards conclude that internal candidates are too embedded in legacy thinking. For HP, which has navigated years of pressure from declining PC demand and cutthroat competition in the printing market, the gambit reflects urgency rather than incrementalism.
Walmsley drew wide attention during her tenure at GSK for restructuring the pharmaceutical giant's consumer health division and later steering the spinoff of Haleon, a major consumer health company. Those moves demonstrated an appetite for portfolio rationalization that HP's board may be counting on as it weighs its own product and business-unit mix.
Whether her record translates to the technology sector remains an open question that Wall Street and industry analysts will scrutinize closely in the months ahead. Continue reading at All News.
